Target intelligence / Profile preview

KDEL endoplasmic reticulum lumen protein retaining receptor (KDELR)

Target
KDELR
Molecular classification
Receptor, Seven-transmembrane protein, G protein-coupled receptor-like protein, Transport protein
01

Overview

The KDEL receptor (KDELR) is a seven-transmembrane protein that plays a critical role in maintaining endoplasmic reticulum (ER) proteostasis by retrieving escaped ER-resident proteins from the Golgi apparatus (UniProt, P24555). It specifically recognizes the C-terminal Lys-Asp-Glu-Leu (KDEL) motif or related sequences on proteins, facilitating their retrograde transport via COPI-coated vesicles (PubMed, 29432131). Recent research has identified the KDEL receptor as a signaling molecule that activates G-protein-mediated pathways, such as Gs and Gq, to regulate Golgi-to-ER trafficking and the unfolded protein response (PubMed, 20813264). In oncology, KDELR expression is often upregulated and correlates with increased metastatic potential and poor prognosis in various cancers (PubMed, 31515468). Furthermore, the receptor is exploited by certain bacterial and plant toxins, such as Cholera toxin and Ricin, to gain entry into the ER (PubMed, 11060024). While not a traditional target for small molecule drugs, it is being explored as a mechanism for the targeted delivery of therapeutic proteins and as a potential target for modulating secretory flux in disease states (PubMed, 33483478).

Other names
ERD2ERD2.1ERD2.2ERD2.3KDEL receptor 1KDEL receptor 2KDEL receptor 3
02

Mechanism of action

Binding of KDEL-motif containing proteins in the Golgi apparatus followed by retrograde transport to the endoplasmic reticulum via COPI-coated vesicles (PubMed, 29432131).

03

Biological functions

Retrograde protein transport (PubMed, 29432131)Endoplasmic reticulum homeostasis (UniProt, P24555)Signal transduction (PubMed, 20813264)Protein folding and quality control (PubMed, 33483478)
04

Disease associations

Cancer (PubMed, 31515468)Infection (PubMed, 11060024)Neurodegenerative disease (PubMed, 28842414)
05

Safety considerations

Disruption of ER proteostasis (PubMed, 33483478)Potential for systemic toxicity due to essential role in protein traffickingOff-target effects on secretory pathway
06

Interacting drugs

Pseudomonas exotoxin A (PubMed, 11060024)

2 more in the full profile.

07

Biomarkers

KDELR1 expression levels (PubMed, 31515468)KDELR2 expression levels (PubMed, 31515468)

Beyond the preview

Go deeper on KDEL endoplasmic reticulum lumen protein retaining receptor (KDELR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KDEL endoplasmic reticulum lumen protein retaining receptor (KDELR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call